Polymorphisms in genes involved in the mechanism of action of methotrexate: are they associated with outcome in rheumatoid arthritis patients?

被引：0
|
作者：
Salazar, Juliana [1 ,2 ]
Moya, Patricia [3 ,4 ]
Altes, Albert [5 ]
Diaz-Torne, Cesar [3 ]
Casademont, Jordi [3 ]
Cerda-Gabaroi, Dacia [6 ]
Corominas, Hector [6 ]
Baiget, Montserrat [1 ,2 ]
机构：
[1] Hosp Santa Creu & Sant Pau, Dept Genet, Barcelona 08025, Spain
[2] CIBERER, U705, Barcelona, Spain
[3] Hosp Santa Creu & Sant Pau, Internal Med Dept, Barcelona 08025, Spain
[4] Univ Autonoma Barcelona, E-08193 Barcelona, Spain
[5] Fundacio Althaia, Hematol Dept, Barcelona, Spain
[6] Hosp Moises Broggi, Rheumatol Dept, Barcelona, Spain
来源：
PHARMACOGENOMICS | 2014年 / 15卷 / 08期
关键词：
5-aminoimidazole-4-carboxamide ribonucleotide transformylase; 5,10-methylenetetrahydrofolate reductase; ATIC; DHFR; dihydrofolate reductase; methotrexate; MTHFR; rheumatoid arthritis; CLINICAL PHARMACOGENETIC MODEL; FUNCTIONAL-ANALYSIS; EFFICACY; RECOMMENDATIONS; MONOTHERAPY; MANAGEMENT; TOXICITY; PREDICT;
D O I：
10.2217/PGS.14.67
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Background: Methotrexate (MTX) is the first-line treatment option for newly diagnosed rheumatoid arthritis (RA) patients. However, 50-70% of the patients respond to treatment and 30% suffer toxicity. Aim: To identify pharmacogenetic markers of outcome in RA patients treated with MTX. Patients & methods: We analyzed 27 genetic variants in DHFR, TYMS, MTHFR, ATIC and CCND1 genes. Results: We included 124 RA patients treated with MTX monotherapy. In multivariate analyses two variants in the MTHFR gene were associated with response, rs17421511 (p = 0.024) and rs1476413 (p = 0.0086), as well as one in the DHFR gene, rs1643650 (p = 0.026). The ATIC rs16853826 variant was associated with toxicity (p = 0.039). Conclusion: MTHFR, DHFR and ATIC genetic variants can be considered as pharmacogenetic markers of outcome in RA patients under MTX monotherapy.
引用
收藏
页码：1079 / 1090
页数：12
相关论文
共 50 条
  • [1] Polymorphisms in Genes Involved in Methotrexate Pathway: Predictor of Response to Methotrexate Therapy in Indian Rheumatoid Arthritis Patients
    Singh, Ankita
    Nair, Harikrishnan
    Gupta, Vikas
    Sekhar, Pradeepta
    Misra, Ramnath
    Aggarwal, Amita
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [2] Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients
    S A Owen
    S L Hider
    P Martin
    I N Bruce
    A Barton
    W Thomson
    The Pharmacogenomics Journal, 2013, 13 : 227 - 234
  • [3] Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients
    Owen, S. A.
    Hider, S. L.
    Martin, P.
    Bruce, I. N.
    Barton, A.
    Thomson, W.
    PHARMACOGENOMICS JOURNAL, 2013, 13 (03): : 227 - 234
  • [4] METHOTREXATE - MECHANISM OF ACTION IN RHEUMATOID-ARTHRITIS
    SEGAL, R
    YARON, M
    TARTAKOVSKY, B
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 1990, 20 (03) : 190 - 199
  • [5] Replication study of polymorphisms associated with response to methotrexate in patients with rheumatoid arthritis
    Rosario López-Rodríguez
    Aida Ferreiro-Iglesias
    Aurea Lima
    Miguel Bernardes
    Andrzej Pawlik
    Agnieszka Paradowska-Gorycka
    Jerzy Świerkot
    Ryszard Slezak
    Vita Dolžan
    Isidoro González-Álvaro
    Javier Narváez
    Rafael Cáliz
    Eva Pérez-Pampín
    Antonio Mera-Varela
    Laura Vidal-Bralo
    José Gorgonio Acuña Ochoa
    Carmen Conde
    Juan J. Gómez-Reino
    Antonio González
    Scientific Reports, 8
  • [6] Replication study of polymorphisms associated with response to methotrexate in patients with rheumatoid arthritis
    Lopez-Rodriguez, Rosario
    Ferreiro-Iglesias, Aida
    Lima, Aurea
    Bernardes, Miguel
    Pawlik, Andrzej
    Paradowska-Gorycka, Agnieszka
    Swierkot, Jerzy
    Slezak, Ryszard
    Dozan, Vita
    Gonzalez-Alvaro, Isidoro
    Narvaez, Javier
    Caliz, Rafael
    Perez-Pampin, Eva
    Mera-Varela, Antonio
    Vidal-Bralo, Laura
    Acuna Ochoa, Jose Gorgonio
    Conde, Carmen
    Gomez-Reino, Juan J.
    Gonzalez, Antonio
    SCIENTIFIC REPORTS, 2018, 8
  • [7] TYMS POLYMORPHISMS AND METHOTREXATE THERAPEUTIC OUTCOME IN RHEUMATOID ARTHRITIS PORTUGUESE PATIENTS: ANALYSIS OF KEY POLYMORPHISMS
    Lima, A.
    Seabra, V.
    Bernardes, M.
    Azevedo, A. R.
    Sousa, H.
    Medeiros, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 341 - 341
  • [8] Methotrexate pharmacokinetic genetic variants are associated with outcome in rheumatoid arthritis patients
    Moya, Patricia
    Salazar, Juliana
    Jesus Arranz, Mara
    Diaz-Torne, Cesar
    del Rio, Elisabeth
    Casademont, Jordi
    Corominas, Hector
    Baiget, Montserrat
    PHARMACOGENOMICS, 2016, 17 (01) : 11 - 25
  • [9] Polymorphism of genes involved in methotrexate pathway: Predictors of response to methotrexate therapy in Indian rheumatoid arthritis patients
    Singh, Ankita
    Gangadharan, Harikrishnan
    Gupta, Vikas
    Patro, Pradeepta S.
    Misra, Ramnath
    Aggarwal, Amita
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2021, 24 (05) : 654 - 662
  • [10] Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers
    Brown, Philip M.
    Pratt, Arthur G.
    Isaacs, John D.
    NATURE REVIEWS RHEUMATOLOGY, 2016, 12 (12) : 731 - 742
12345